Drawing for CAREPOINT HEALTH

USPTO serial 97716106

CAREPOINT HEALTH

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
—
Examiner
HILLIARD, JESSICA LYNN
Law office
TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CAREPOINT HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CHARLES F. LUCE, JR.

CHARLES F. LUCE, JR. FENNEMORE CRAIG, P.C.3615 DELGANY STREET, SUITE 110016 MARKET SQUARE, 6TH FLOORDENVER, CO 80216-3997

Goods and services

ClassDescriptionStatusFirst use
044Telemedicine servicesACTIVEJun 29, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2025MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL—
Jul 16, 2025ABN3ABANDONMENT - AFTER EX PARTE APPEAL—
Jul 16, 2025EXPTEXPARTE APPEAL TERMINATED—
Jul 16, 2025EXDDEXPARTE APPEAL DISMISSED—
Oct 18, 2024EXPIEX PARTE APPEAL-INSTITUTED—
Oct 18, 2024EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jul 15, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 15, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 19, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 19, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 19, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 18, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 18, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 13, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Dec 13, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Sep 18, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2023DOCKASSIGNED TO EXAMINER—
Jan 10, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 16, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance